Hemodynamic consequences of neuropeptide Y-induced obesity.

作者: M. L. G. Correia , D. A. Morgan , W. I. Sivitz , A. L. Mark , W. G. Haynes

DOI: 10.1016/S0895-7061(01)02270-1

关键词:

摘要: Abstract Background Acute central nervous system administration of neuropeptide Y (NPY) elicits variable hemodynamic responses. Chronic intracerebroventricular (ICV) NPY produces obesity in rats. Obesity has been shown to increase arterial pressure. Methods In this study we examined the chronic effects NPY-induced obesity. Sprague-Dawley rats were implanted with radiotelemetry transmitters continuously record heart rate and pressure conscious state. Neuropeptide or vehicle was delivered into third cerebral ventricle by osmotic minipumps over 2 weeks. Three groups studied: vehicle, NPY-treated (free-fed), (pair-fed vehicle-treated rats). Results increased food intake body weight free-fed animals, substantially augmented visceral adiposity both free- pair-fed Despite adiposity, ICV unstressed did not decreased rate, suggesting a sympathoinhibitory effect. Conclusions induced 2-week does pressure, perhaps indicating inhibition sympathetic outflow that may oppose pressor effect adiposity.

参考文章(22)
C. J. Billington, J. E. Briggs, M. Grace, A. S. Levine, Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 260, ,(1991) , 10.1152/AJPREGU.1991.260.2.R321
L. N. Kaufman, M. M. Peterson, S. M. Smith, Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets. American Journal of Physiology-endocrinology and Metabolism. ,vol. 260, pp. 595- 5100 ,(1991) , 10.1152/AJPENDO.1991.260.1.E95
M. Egawa, H. Yoshimatsu, G. A. Bray, Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 260, ,(1991) , 10.1152/AJPREGU.1991.260.2.R328
Neal A. Scott, Victoria Webb, Jaroslav H. Boublik, Jean Rivier, Marvin R. Brown, The cardiovascular actions of centrally administered neuropeptide Y. Regulatory Peptides. ,vol. 25, pp. 247- 258 ,(1989) , 10.1016/0167-0115(89)90266-8
Allyn L. Mark, Richard A. Shaffer, Marcelo L.G. Correia, Donald A. Morgan, Curt D. Sigmund, William G. Haynes, Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. Journal of Hypertension. ,vol. 17, pp. 1949- 1953 ,(1999) , 10.1097/00004872-199917121-00026
Robert A. Kesterson, Dennis Huszar, Catherine A. Lynch, Richard B. Simerly, Roger D. Cone, Induction of Neuropeptide Y Gene Expression in the Dorsal Medial Hypothalamic Nucleus in Two Models of the Agouti Obesity Syndrome Molecular Endocrinology. ,vol. 11, pp. 630- 637 ,(1997) , 10.1210/MEND.11.5.9921
J.G Wettstein, B Earley, J.L Junien, Central nervous system pharmacology of neuropeptide Y. Pharmacology & Therapeutics. ,vol. 65, pp. 397- 414 ,(1995) , 10.1016/0163-7258(95)98598-K
James B. Young, Deborah Mullen, Lewis Landsberg, Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. Metabolism-clinical and Experimental. ,vol. 27, pp. 1711- 1714 ,(1978) , 10.1016/0026-0495(78)90256-1
TC Westfall, SP Han, M. Knuepfer, J. Martin, XL Chen, K. Valle, A. Ciarleglio, L. Naes, Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide. British Journal of Clinical Pharmacology. ,vol. 30, ,(1990) , 10.1111/J.1365-2125.1990.TB05472.X
N Zarjevski, I Cusin, R Vettor, F Rohner-Jeanrenaud, B Jeanrenaud, Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity Endocrinology. ,vol. 133, pp. 1753- 1758 ,(1993) , 10.1210/ENDO.133.4.8404618